This site is intended for healthcare professionals
News

FDA accepts NDA for oral relugolix for treatment of advanced prostate cancer.- Myovant Sciences

Read time: 1 mins
Last updated:23th Jun 2020
Published:23th Jun 2020
Condition: Prostate Cancer
Type: drug
Register free for full access to medthority.com